Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?. Bleeding Thromb Vascul Biol [Internet]. 2023 Aug. 3 [cited 2025 Jun. 7];2(3). Available from: https://www.btvb.org/btvb/article/view/90